mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.008 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.008 |
mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.01 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.01 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |